US$ 23.77
dosing for ghk-cu peptide subcutaneous protocol ghk-cu administration subcutaneous GHK-Cu Dosage and Protocol: A Medical Provider's Guide to the 30 GHK-CU Peptide Dosage: Complete Guide
Description
Thymosin Alpha-1's approval record in more than 30 countries is frequently cited as evidence that the FDA's risk characterization is inconsistent with global clinical experience

doi: 10.1212/WNL.0b013e3181e0f7b3

Hematoma thickness decreased by at least 50% at 180 days post-procedure in 29 patients (72.5%) with at least one follow-up CT scan, except for one patient whose hematoma remained stable

This concentration is similar to that used in GHK-Cu preparations for aging skin
